Martin Brenner

Martin Brenner

Chief Executive Officer at IBIO, INC.

Net worth: 37 048 $ as of 30/03/2024

54 year
Health Technology
Consumer Services

Profile

Martin B.
Brenner
's current job is Chief Executive & Scientific Officer at iBio, Inc. Formerly, Dr. Brenner worked as Senior Director & Head-BioScience at AstraZeneca PLC from 2012 to 2013.
He then served as Executive Director-Diabetes & NASH at Merck Research Laboratories Massachusetts LLC from 2013 to 2016.
Dr. Brenner was also the Head-Insulin Resistance Group at Pfizer Inc. Additionally, he held the position of Chief Scientific Officer at Recursion Pharmaceuticals, Inc. from 2017 to 2018.
From 2019 to 2020, Dr. Brenner worked as Chief Scientific Officer & Senior Vice President at Pfenex, Inc. He also served as VP & Head-Research & Early Development at Stoke Therapeutics, Inc. from 2016 to 2017.
Dr. Brenner obtained a doctorate degree from Ludwig-Maximilians-Universität München.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/10/2023 9,125 ( 0.11% ) 37 048 $ 30/03/2024

Martin Brenner active positions

CompaniesPositionStart
IBIO, INC. Chief Executive Officer 19/01/2023
All active positions of Martin Brenner

Former positions of Martin Brenner

CompaniesPositionEnd
PFENEX INC. Chief Tech/Sci/R&D Officer 30/09/2020
RECURSION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 31/12/2017
STOKE THERAPEUTICS, INC. Corporate Officer/Principal 31/12/2016
Director/Board Member 31/12/2015
ASTRAZENECA PLC Corporate Officer/Principal 31/12/2012
See the detail of Martin Brenner's experience

Training of Martin Brenner

Ludwig-Maximilians-Universität München Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Brenner's experience

Connections

77

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

RECURSION PHARMACEUTICALS, INC.

Health Technology

IBIO, INC.

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Martin Brenner